Equities

Bure Equity AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Bure Equity AB

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (SEK)202.00
  • Today's Change-1.60 / -0.79%
  • Shares traded110.93k
  • 1 Year change-50.00%
  • Beta1.7869
Data delayed at least 15 minutes, as of Feb 09 2026 17:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.

  • Revenue in SEK (TTM)254.00m
  • Net income in SEK-5.39bn
  • Incorporated1992
  • Employees11.00
  • Location
    Bure Equity ABNybrogatan 6STOCKHOLM 114 34SwedenSWE
  • Phone+46 86140020
  • Fax+46 86140038
  • Websitehttps://www.bure.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TR Property Investment Trust plc-224.82m-442.54m13.02bn0.00--0.9506-----0.1135-0.1135-0.05773.51-0.0141-------2.782.08-3.022.18--68.67--52.75---3.650.0133174.65-103.86---113.98----2.58
Edinburgh Investment Trust PLC1.10bn992.46m13.31bn0.0014.170.968--12.070.56510.56510.62088.270.0693--16.61--6.2311.086.2411.3091.5593.0890.0192.03----0.093632.26-33.13---35.12----0.1045
Georgia Capital PLC5.27bn5.25bn13.82bn45.002.760.9657--2.6211.7411.7411.5333.510.4075----9,532,395.0040.6314.1740.6314.17----99.7397.71----0.00---40.24-24.22-40.48-8.64----
Vietnam Enterprise Investments Ltd1.03bn695.24m14.15bn0.0027.071.11--13.680.29660.29660.45447.210.063--20.43--4.246.184.386.2193.2996.3467.1774.84--40.620.0550.008.5427.479.0832.40----
Temple Bar Investment Trust PLC2.14bn2.01bn14.29bn0.006.911.247.096.680.57490.57490.60983.210.1875--26.94--17.662.1117.722.1396.6775.9094.1666.08----0.0758156.9056.63-8.2260.72-8.59--1.82
Is Yatirim Menkul Degerler AS299.15bn1.33bn14.45bn603.0010.752.438.390.04834.334.33972.3919.1317.494,275.3726.282,305,537,000.009.5711.4928.4038.140.39291.230.54730.91411.42--0.175157.5349.3631.33-31.1670.4352.93127.33
Sequoia Economic Infrastrctr Incm Fd Ltd1.20bn977.27m14.66bn0.0015.580.8551--12.210.05140.05140.06290.93670.0648------5.275.055.325.1882.3783.6781.3780.62----0.0225123.59-26.70---27.73----1.96
Herald Investment Trust plc570.74m389.02m14.76bn0.0039.840.9828--25.850.630.630.903625.540.0355--8.39--2.426.602.426.6173.3187.4268.1686.09----0.000.00139.90-10.13179.08-11.11----
JPMorgan Japanese Investment Trust PLC3.07bn2.97bn14.87bn0.005.141.01--4.851.491.491.547.580.2183--40.00--21.093.2221.643.3097.8785.4096.6179.46----0.050730.0538.31-2.2040.56-2.30--11.27
Bure Equity AB254.00m-5.39bn15.10bn11.00--0.741--59.43-72.64-72.643.43274.750.0109--11.2921,166,670.00-23.0811.49-23.2511.52-----2,121.261,211.22--0.02830.01238.002.97-15.4421.016.32--22.42
Schiehallion Fund Ltd3.08bn2.96bn15.36bn0.005.241.14--4.990.32050.32050.33351.470.2541--175.12--24.442.5724.532.5996.7979.1996.1675.82----0.000.00112.7654.56128.6954.81----
Bankers Investment Trust PLC2.83bn2.66bn15.69bn0.006.350.9096--5.540.20720.20720.21561.450.1476--50.00--13.878.5913.908.6496.0193.2393.9290.28----0.080322.59-5.4726.66-5.7729.44--4.96
Aberforth Smaller Companies Trust plc1.40bn1.18bn16.16bn0.0014.110.95--11.531.181.181.4017.450.0769--33.99--6.487.856.657.9891.3892.1784.3387.25--22.250.051336.34-33.22---36.52----7.04
Worldwide Healthcare Trust PLC-1.83bn-2.07bn16.75bn0.00--1.00-----0.3233-0.3233-0.30733.54-0.0818-------9.262.87-9.853.03--73.57--69.87----0.0023.15-180.77---204.28-----0.8131
Rosebank Industries PLC-1.23tn-1.23tn16.93bn----4.59----------0.7383----------------------------0.0311--------------
Data as of Feb 09 2026. Currency figures normalised to Bure Equity AB's reporting currency: Swedish Krona SEK

Institutional shareholders

33.36%Per cent of shares held by top holders
HolderShares% Held
Fj�rde AP-fondenas of 31 Dec 20245.67m7.65%
AMF Fonder ABas of 31 Dec 20244.83m6.51%
SEB Funds ABas of 31 Dec 20254.34m5.85%
F�rsta AP-fondenas of 31 Dec 20242.85m3.85%
The Vanguard Group, Inc.as of 07 Jan 20262.06m2.77%
Handelsbanken Fonder ABas of 31 Jan 20261.28m1.72%
Dimensional Fund Advisors LPas of 31 Dec 20251.16m1.57%
Norges Bank Investment Managementas of 30 Jun 20251.13m1.52%
BlackRock Fund Advisorsas of 09 Jan 2026808.05k1.09%
Quartile Fonder ABas of 28 Nov 2025615.18k0.83%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.